Abstract
Background: An important aspect in the treatment of patients with intestinal yersiniosis is the administration of effective antibiotic therapy. Performed research aimed to determine the spectrum and level of antimicrobial activity of 2H-pyrano[2,3- c]pyridine derivatives on the museum and clinical strains of gram-negative microorganisms Yersinia enterocolitica.
Methodology: The object of the study was 28 synthetic derivatives of 2H-pyrano[2,3- c]pyridine. The compounds were studied according to their chemical structure. We used the method of serial dilutions in Muller-Hinton liquid nutrient medium with a museum’s and clinical strains of Y.enterocolitica.
Results: Studies indicate the promise of further study of the properties of 2H- pyrono[2,3-c]pyridine to create an effective antimicrobial medicine. According to the results of studies on action of antimicrobial compounds synthesized on the basis of 2H-pyrano[2,3-с]pyridine derivatives, it was found that the MIC of compounds for all Y. enterocolitica strains was 100.0 μg/ml. The MBCC of most cultures of Yersinia (72.3 %) was 200.0 μg/ml. Compound 2{3} had a pronounced antiyersiniotic activity, the inhibitory effect of which was manifested at a concentration of 25.0 μg/ml. Retarding the growth of most Yersinia strains (95.3%) with a MIC of 50.0 μg/ml, the MIC of compounds ranged from 50.0 to 200.0 μg/ml. After statistical data processing, pyridine derivatives (compounds 2{3} and 3{5}) were identified, possessing an effective bacteriostatic and bactericidal effect on Y. enterocolitica strains.
Conclusions: The results of the research showed a high antimicrobial activity of 2H- pyrano[2,3-c]pyridine derivatives. The highest activity against Y. enterocolitica was found for 2-N2-arylimino-5-hydroxy-methyl-8-methyl-2H-pyrano[2,3-c]pyridine-3-N1- aricarboxamide derivatives.
References
GBD 2019 Viewpoint Collaborators. Five insights from the Global Burden of Disease Study 2019. Lancet 2020; 396(10258): 1135-1159. https://doi.org/10.1016/S0140-6736(20)31404-5
Khanna K, Kohli SK, Kaur R, et al. Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle. Phytomedicine 2021; 85: 153361. https://doi.org/10.1016/j.phymed.2020.153361
Płusa T. The actual threat of COVID-19. Pol Merkur Lekarski 2020; 48(287): 354-360.
Kowal M, Sorokowski P, Sorokowska A, Lebuda I, Groyecka-Bernard A, Białek M, et al. Dread in Academia - How COVID-19 affects science and scientists. Anthropol Rev 2020; 83(4): 387-394. https://doi.org/10.2478/anre-2020-0028
Rahman A, Bonny TS, Stonsaovapak S, Ananchaipattana C. Yersinia enterocolitica: Epidemiological Studies and Outbreaks. J Pathog 2011; 2011: 239391. https://doi.org/10.4061/2011/239391
Al-Saadi LS, Ali A, Waly MI, Al-Zuhaibi KM. Impact of dietary patterns and nutritional status on the academic performance of Omani school students. J Pharm Nutr Sci 2020; 10(3): 74-87. https://doi.org/10.29169/1927-5951.2020.10.03.1
Tkachenko A, Pogozhykh D, Onishchenko A, Myasoedov V, Podrigalo L, Klochkov V, et al. Gadolinium Orthovanadate GdVO4: Eu3+ Nanoparticles Ameliorate Carrageenan-Induced Intestinal Inflammation. J Pharm Nutr Sci 2021; 11(1): 40-48. https://doi.org/10.29169/1927-5951.2021.11.06
Wielgos K, Setkowicz W, Pasternak G, Lewandowicz-Uszyńska A. Management of acute gastroenteritis in children. Pol Merkur Lekarski 2019; 47(278): 76-79.
Aziz M, Yelamanchili VS. Yersinia Enterocolitica. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 6, 2021.
MacDonald E, Einöder-Moreno M, Borgen K, et al. National outbreak of Yersinia enterocolitica infections in military and civilian populations associated with consumption of mixed salad, Norway, 2014. Euro Surveill 2016; 21(34): 30321. https://doi.org/10.2807/1560-7917.ES.2016.21.34.30321
Murros A, Säde E, Johansson P, Korkeala H, Fredriksson-Ahomaa M, Björkroth J. Characterization of European Yersinia enterocolitica 1A strains using restriction fragment length polymorphism and multilocus sequence analysis. Lett Appl Microbiol 2016; 63(4): 282-288. https://doi.org/10.1111/lam.12626
On SLW, Zhang Y, Gehring A, et al. Elastic Light Scatter Pattern Analysis for the Expedited Detection of Yersinia Species in Pork Mince: Proof of Concept. Front Microbiol 2021; 12: 641801. https://doi.org/10.3389/fmicb.2021.641801
Fredriksson-Ahomaa M, Murros-Kontiainen A, Säde E, Puolanne E, Björkroth J. High number of Yersinia enterocolitica 4/O: 3 in cold-stored modified atmosphere-packed pig cheek meat. Int J Food Microbiol 2012; 155(1-2): 69-72. https://doi.org/10.1016/j.ijfoodmicro.2012.01.021
Bohdanov S, Polyvianna Y, Chumachenko T, Chumachenko D. Forecasting of salmonellosis epidemic proces in Ukraine using autoregressive integrated moving average model. Przegl Epidemiol 2020; 74(2): 346-354. https://doi.org/10.32394/pe.74.27
El-Sayed Ali T. Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents. Eur J Med Chem 2009; 44(11): 4385-4392. https://doi.org/10.1016/j.ejmech.2009.05.031
Amorim R, de Meneses MDF, Borges JC, et al. Thieno[2,3-b]pyridine derivatives: a new class of antiviral drugs against Mayaro virus. Arch Virol 2017; 162(6): 1577-1587. https://doi.org/10.1007/s00705-017-3261-0
Chiacchio MA, Iannazzo D, Romeo R, Giofrè SV, Legnani L. Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Biologically Active Agents. Curr Med Chem 2019; 26(40): 7166-7195. https://doi.org/10.2174/0929867325666180904125400
Khayyat S, Amr Ael-G. Synthesis and biological activities of some new (Nα-dinicotinoyl)-bis-L-leucyl linear and macrocyclic peptides. Molecules 2014; 19(8): 10698-10716. Published 2014 Jul 24. https://doi.org/10.3390/molecules190810698
Jahnz-Rózyk K. Possibilities of clinical and laboratory diagnosis of severe respiratory infections. Pol Merkur Lekarski 2012; 33(197): 241-244.
Pokhil SI, Bondarenko AV, Bocharova TV, Lepilina KM, Lytvynenko MV, Gargin VV. Implementation and analysis of Babesia immunoassay testing. Pol Merkur Lekarski 2020; 48(285): 170-173.
Torianyk II. Biological method for babesiosis detection: the unified version in vivo. Wiad Lek 2021; 74(2): 268-272. https://doi.org/10.36740/WLek202102117
Avilova O, Shyian D, Marakushin D, Erokhina V, Gargin V. Ultrastructural changes in the organs of the immune system under the influence of xenobiotics. Georgian Med News 2018(279): 132-137.
Lenters V, Thomsen C, Smit LA, et al. Serum concentrations of polybrominated diphenyl ethers (PBDEs) and a polybrominated biphenyl (PBB) in men from Greenland, Poland and Ukraine. Environ Int 2013; 61: 8-16. https://doi.org/10.1016/j.envint.2013.09.001
Bondarenko AV, Torianyk II, Pokhil SI, et al. Seroprevalence of babesiosis in immunocompetent and immunocompromised individuals. Pol Merkur Lekarski 2021; 49(291): 193-197.
Kovach I, Kravchenko L, Khotimska Y, Nazaryan R, Gargin V. Influence of ozone therapy on oral tissue in modeling of chronic recurrent aphthous stomatitis. Georgian Med News 2017; (264): 115-119.
Muriyati, Arimbi, Asnidar, Safruddin, Thahir AIA. The association between adiponectin gene polymorphism and waist circumference changes in obese/overweight adults after aerobic exercise and diet treatment. J Pharm Nutr Sci 2019; 9(5): 247-250. https://doi.org/10.29169/1927-5951.2019.09.05.2
Popova TM, Kryvenko LS, Tishchenko OV, et al. Effect of Electronic Cigarettes on Oral Microbial Flora. J Pharm Nutr Sci 2021; 11(1). https://doi.org/10.29169/1927-5951.2021.11.08
Torianyk II. Cultural method in babesiosis pathogens diagnosis: current state of the problem. Wiad Lek 2021; 74(5): 1204-1207. https://doi.org/10.36740/WLek202105129
Jakobsen AM, Bahl MI, Buschhardt T, et al. Bacterial community analysis for investigating bacterial transfer from tonsils to the pig carcass. Int J Food Microbiol 2019; 295: 8-18. https://doi.org/10.1016/j.ijfoodmicro.2019.02.003
Prachayasittikul S, Pingaew R, Worachartcheewan A, et al. Roles of Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Anticancer Agents. Mini Rev Med Chem 2017; 17(10): 869-901. https://doi.org/10.2174/1389557516666160923125801
Pelchen-Matthews A, Ryom L, Borges ÁH, et al. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort. AIDS 2018; 32(16): 2405-2416. https://doi.org/10.1097/QAD.0000000000001967
Shepherd L, Borges Á, Ledergerber B, et al.: Infection-related and -unrelated malignancies, HIV and the aging population. HIV Med 2016; 17(8): 590-600. https://doi.org/10.1111/hiv.12359
Zoufaly A, Cozzi-Lepri A, Reekie J, et al. Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe. PLoS One 2014; 9(1): e87160. Published 2014 Jan 31. https://doi.org/10.1371/journal.pone.0087160
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2021 V.Yu. Ivannik, I.I. Torianyk, T.M. Moiseienko, A.I. Skliar, R.F. Yeromenko, V.V. Hnatiuk, L.V. Podrigalo, R.S. Nazaryan, N.M. Mikhailenko, V.V. Gargin